img

Global Immunoinformatics Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Immunoinformatics Market Research Report 2024

Immunoinformatics is a field of science that encompasses high-throughput genomic and bioinformatics approaches to immunology. The field's main aim is to convert immunological data into computational problems, solve these problems using mathematical and computational approaches and then convert these results into immunologically meaningful interpretations.
According to MRAResearch’s new survey, global Immunoinformatics market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Immunoinformatics market research.
Key companies engaged in the Immunoinformatics industry include EpiVax, Novozymes Biopharma, ioGenetics, International Society of Vaccines, IMGT, Dassault Systemes, Certara, Chemical Computing Group and Compugen, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Immunoinformatics were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Immunoinformatics market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Immunoinformatics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


EpiVax
Novozymes Biopharma
ioGenetics
International Society of Vaccines
IMGT
Dassault Systemes
Certara
Chemical Computing Group
Compugen
Genedata AG
Insilico Biotechnology AG
Leadscope Inc
Nimbus Discovery
Strand Life Sciences
Schrodinger
Simulation Plus
Rosa & Co
Segment by Type
Cancer Diagnosis & Therapy
Reverse Vaccinology
Immune System Modeling

Segment by Application


Allergy Prediction Databases
Analysis Resource Database
International Immunogenetics System
The Ontology of Immune Epitopes
Immune Epitope Database
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Immunoinformatics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunoinformatics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Cancer Diagnosis & Therapy
1.2.3 Reverse Vaccinology
1.2.4 Immune System Modeling
1.3 Market by Application
1.3.1 Global Immunoinformatics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Allergy Prediction Databases
1.3.3 Analysis Resource Database
1.3.4 International Immunogenetics System
1.3.5 The Ontology of Immune Epitopes
1.3.6 Immune Epitope Database
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immunoinformatics Market Perspective (2018-2033)
2.2 Immunoinformatics Growth Trends by Region
2.2.1 Global Immunoinformatics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Immunoinformatics Historic Market Size by Region (2018-2023)
2.2.3 Immunoinformatics Forecasted Market Size by Region (2024-2033)
2.3 Immunoinformatics Market Dynamics
2.3.1 Immunoinformatics Industry Trends
2.3.2 Immunoinformatics Market Drivers
2.3.3 Immunoinformatics Market Challenges
2.3.4 Immunoinformatics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunoinformatics Players by Revenue
3.1.1 Global Top Immunoinformatics Players by Revenue (2018-2023)
3.1.2 Global Immunoinformatics Revenue Market Share by Players (2018-2023)
3.2 Global Immunoinformatics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immunoinformatics Revenue
3.4 Global Immunoinformatics Market Concentration Ratio
3.4.1 Global Immunoinformatics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunoinformatics Revenue in 2022
3.5 Immunoinformatics Key Players Head office and Area Served
3.6 Key Players Immunoinformatics Product Solution and Service
3.7 Date of Enter into Immunoinformatics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunoinformatics Breakdown Data by Type
4.1 Global Immunoinformatics Historic Market Size by Type (2018-2023)
4.2 Global Immunoinformatics Forecasted Market Size by Type (2024-2033)
5 Immunoinformatics Breakdown Data by Application
5.1 Global Immunoinformatics Historic Market Size by Application (2018-2023)
5.2 Global Immunoinformatics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Immunoinformatics Market Size (2018-2033)
6.2 North America Immunoinformatics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Immunoinformatics Market Size by Country (2018-2023)
6.4 North America Immunoinformatics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immunoinformatics Market Size (2018-2033)
7.2 Europe Immunoinformatics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Immunoinformatics Market Size by Country (2018-2023)
7.4 Europe Immunoinformatics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immunoinformatics Market Size (2018-2033)
8.2 Asia-Pacific Immunoinformatics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Immunoinformatics Market Size by Region (2018-2023)
8.4 Asia-Pacific Immunoinformatics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immunoinformatics Market Size (2018-2033)
9.2 Latin America Immunoinformatics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Immunoinformatics Market Size by Country (2018-2023)
9.4 Latin America Immunoinformatics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunoinformatics Market Size (2018-2033)
10.2 Middle East & Africa Immunoinformatics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Immunoinformatics Market Size by Country (2018-2023)
10.4 Middle East & Africa Immunoinformatics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 EpiVax
11.1.1 EpiVax Company Detail
11.1.2 EpiVax Business Overview
11.1.3 EpiVax Immunoinformatics Introduction
11.1.4 EpiVax Revenue in Immunoinformatics Business (2018-2023)
11.1.5 EpiVax Recent Development
11.2 Novozymes Biopharma
11.2.1 Novozymes Biopharma Company Detail
11.2.2 Novozymes Biopharma Business Overview
11.2.3 Novozymes Biopharma Immunoinformatics Introduction
11.2.4 Novozymes Biopharma Revenue in Immunoinformatics Business (2018-2023)
11.2.5 Novozymes Biopharma Recent Development
11.3 ioGenetics
11.3.1 ioGenetics Company Detail
11.3.2 ioGenetics Business Overview
11.3.3 ioGenetics Immunoinformatics Introduction
11.3.4 ioGenetics Revenue in Immunoinformatics Business (2018-2023)
11.3.5 ioGenetics Recent Development
11.4 International Society of Vaccines
11.4.1 International Society of Vaccines Company Detail
11.4.2 International Society of Vaccines Business Overview
11.4.3 International Society of Vaccines Immunoinformatics Introduction
11.4.4 International Society of Vaccines Revenue in Immunoinformatics Business (2018-2023)
11.4.5 International Society of Vaccines Recent Development
11.5 IMGT
11.5.1 IMGT Company Detail
11.5.2 IMGT Business Overview
11.5.3 IMGT Immunoinformatics Introduction
11.5.4 IMGT Revenue in Immunoinformatics Business (2018-2023)
11.5.5 IMGT Recent Development
11.6 Dassault Systemes
11.6.1 Dassault Systemes Company Detail
11.6.2 Dassault Systemes Business Overview
11.6.3 Dassault Systemes Immunoinformatics Introduction
11.6.4 Dassault Systemes Revenue in Immunoinformatics Business (2018-2023)
11.6.5 Dassault Systemes Recent Development
11.7 Certara
11.7.1 Certara Company Detail
11.7.2 Certara Business Overview
11.7.3 Certara Immunoinformatics Introduction
11.7.4 Certara Revenue in Immunoinformatics Business (2018-2023)
11.7.5 Certara Recent Development
11.8 Chemical Computing Group
11.8.1 Chemical Computing Group Company Detail
11.8.2 Chemical Computing Group Business Overview
11.8.3 Chemical Computing Group Immunoinformatics Introduction
11.8.4 Chemical Computing Group Revenue in Immunoinformatics Business (2018-2023)
11.8.5 Chemical Computing Group Recent Development
11.9 Compugen
11.9.1 Compugen Company Detail
11.9.2 Compugen Business Overview
11.9.3 Compugen Immunoinformatics Introduction
11.9.4 Compugen Revenue in Immunoinformatics Business (2018-2023)
11.9.5 Compugen Recent Development
11.10 Genedata AG
11.10.1 Genedata AG Company Detail
11.10.2 Genedata AG Business Overview
11.10.3 Genedata AG Immunoinformatics Introduction
11.10.4 Genedata AG Revenue in Immunoinformatics Business (2018-2023)
11.10.5 Genedata AG Recent Development
11.11 Insilico Biotechnology AG
11.11.1 Insilico Biotechnology AG Company Detail
11.11.2 Insilico Biotechnology AG Business Overview
11.11.3 Insilico Biotechnology AG Immunoinformatics Introduction
11.11.4 Insilico Biotechnology AG Revenue in Immunoinformatics Business (2018-2023)
11.11.5 Insilico Biotechnology AG Recent Development
11.12 Leadscope Inc
11.12.1 Leadscope Inc Company Detail
11.12.2 Leadscope Inc Business Overview
11.12.3 Leadscope Inc Immunoinformatics Introduction
11.12.4 Leadscope Inc Revenue in Immunoinformatics Business (2018-2023)
11.12.5 Leadscope Inc Recent Development
11.13 Nimbus Discovery
11.13.1 Nimbus Discovery Company Detail
11.13.2 Nimbus Discovery Business Overview
11.13.3 Nimbus Discovery Immunoinformatics Introduction
11.13.4 Nimbus Discovery Revenue in Immunoinformatics Business (2018-2023)
11.13.5 Nimbus Discovery Recent Development
11.14 Strand Life Sciences
11.14.1 Strand Life Sciences Company Detail
11.14.2 Strand Life Sciences Business Overview
11.14.3 Strand Life Sciences Immunoinformatics Introduction
11.14.4 Strand Life Sciences Revenue in Immunoinformatics Business (2018-2023)
11.14.5 Strand Life Sciences Recent Development
11.15 Schrodinger
11.15.1 Schrodinger Company Detail
11.15.2 Schrodinger Business Overview
11.15.3 Schrodinger Immunoinformatics Introduction
11.15.4 Schrodinger Revenue in Immunoinformatics Business (2018-2023)
11.15.5 Schrodinger Recent Development
11.16 Simulation Plus
11.16.1 Simulation Plus Company Detail
11.16.2 Simulation Plus Business Overview
11.16.3 Simulation Plus Immunoinformatics Introduction
11.16.4 Simulation Plus Revenue in Immunoinformatics Business (2018-2023)
11.16.5 Simulation Plus Recent Development
11.17 Rosa & Co
11.17.1 Rosa & Co Company Detail
11.17.2 Rosa & Co Business Overview
11.17.3 Rosa & Co Immunoinformatics Introduction
11.17.4 Rosa & Co Revenue in Immunoinformatics Business (2018-2023)
11.17.5 Rosa & Co Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Immunoinformatics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Cancer Diagnosis & Therapy
Table 3. Key Players of Reverse Vaccinology
Table 4. Key Players of Immune System Modeling
Table 5. Global Immunoinformatics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Immunoinformatics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Immunoinformatics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Immunoinformatics Market Share by Region (2018-2023)
Table 9. Global Immunoinformatics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Immunoinformatics Market Share by Region (2024-2033)
Table 11. Immunoinformatics Market Trends
Table 12. Immunoinformatics Market Drivers
Table 13. Immunoinformatics Market Challenges
Table 14. Immunoinformatics Market Restraints
Table 15. Global Immunoinformatics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Immunoinformatics Market Share by Players (2018-2023)
Table 17. Global Top Immunoinformatics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunoinformatics as of 2022)
Table 18. Ranking of Global Top Immunoinformatics Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Immunoinformatics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Immunoinformatics Product Solution and Service
Table 22. Date of Enter into Immunoinformatics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Immunoinformatics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Immunoinformatics Revenue Market Share by Type (2018-2023)
Table 26. Global Immunoinformatics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Immunoinformatics Revenue Market Share by Type (2024-2033)
Table 28. Global Immunoinformatics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Immunoinformatics Revenue Market Share by Application (2018-2023)
Table 30. Global Immunoinformatics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Immunoinformatics Revenue Market Share by Application (2024-2033)
Table 32. North America Immunoinformatics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Immunoinformatics Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Immunoinformatics Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Immunoinformatics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Immunoinformatics Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Immunoinformatics Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Immunoinformatics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Immunoinformatics Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Immunoinformatics Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Immunoinformatics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Immunoinformatics Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Immunoinformatics Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Immunoinformatics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Immunoinformatics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Immunoinformatics Market Size by Country (2024-2033) & (US$ Million)
Table 47. EpiVax Company Detail
Table 48. EpiVax Business Overview
Table 49. EpiVax Immunoinformatics Product
Table 50. EpiVax Revenue in Immunoinformatics Business (2018-2023) & (US$ Million)
Table 51. EpiVax Recent Development
Table 52. Novozymes Biopharma Company Detail
Table 53. Novozymes Biopharma Business Overview
Table 54. Novozymes Biopharma Immunoinformatics Product
Table 55. Novozymes Biopharma Revenue in Immunoinformatics Business (2018-2023) & (US$ Million)
Table 56. Novozymes Biopharma Recent Development
Table 57. ioGenetics Company Detail
Table 58. ioGenetics Business Overview
Table 59. ioGenetics Immunoinformatics Product
Table 60. ioGenetics Revenue in Immunoinformatics Business (2018-2023) & (US$ Million)
Table 61. ioGenetics Recent Development
Table 62. International Society of Vaccines Company Detail
Table 63. International Society of Vaccines Business Overview
Table 64. International Society of Vaccines Immunoinformatics Product
Table 65. International Society of Vaccines Revenue in Immunoinformatics Business (2018-2023) & (US$ Million)
Table 66. International Society of Vaccines Recent Development
Table 67. IMGT Company Detail
Table 68. IMGT Business Overview
Table 69. IMGT Immunoinformatics Product
Table 70. IMGT Revenue in Immunoinformatics Business (2018-2023) & (US$ Million)
Table 71. IMGT Recent Development
Table 72. Dassault Systemes Company Detail
Table 73. Dassault Systemes Business Overview
Table 74. Dassault Systemes Immunoinformatics Product
Table 75. Dassault Systemes Revenue in Immunoinformatics Business (2018-2023) & (US$ Million)
Table 76. Dassault Systemes Recent Development
Table 77. Certara Company Detail
Table 78. Certara Business Overview
Table 79. Certara Immunoinformatics Product
Table 80. Certara Revenue in Immunoinformatics Business (2018-2023) & (US$ Million)
Table 81. Certara Recent Development
Table 82. Chemical Computing Group Company Detail
Table 83. Chemical Computing Group Business Overview
Table 84. Chemical Computing Group Immunoinformatics Product
Table 85. Chemical Computing Group Revenue in Immunoinformatics Business (2018-2023) & (US$ Million)
Table 86. Chemical Computing Group Recent Development
Table 87. Compugen Company Detail
Table 88. Compugen Business Overview
Table 89. Compugen Immunoinformatics Product
Table 90. Compugen Revenue in Immunoinformatics Business (2018-2023) & (US$ Million)
Table 91. Compugen Recent Development
Table 92. Genedata AG Company Detail
Table 93. Genedata AG Business Overview
Table 94. Genedata AG Immunoinformatics Product
Table 95. Genedata AG Revenue in Immunoinformatics Business (2018-2023) & (US$ Million)
Table 96. Genedata AG Recent Development
Table 97. Insilico Biotechnology AG Company Detail
Table 98. Insilico Biotechnology AG Business Overview
Table 99. Insilico Biotechnology AG Immunoinformatics Product
Table 100. Insilico Biotechnology AG Revenue in Immunoinformatics Business (2018-2023) & (US$ Million)
Table 101. Insilico Biotechnology AG Recent Development
Table 102. Leadscope Inc Company Detail
Table 103. Leadscope Inc Business Overview
Table 104. Leadscope Inc Immunoinformatics Product
Table 105. Leadscope Inc Revenue in Immunoinformatics Business (2018-2023) & (US$ Million)
Table 106. Leadscope Inc Recent Development
Table 107. Nimbus Discovery Company Detail
Table 108. Nimbus Discovery Business Overview
Table 109. Nimbus Discovery Immunoinformatics Product
Table 110. Nimbus Discovery Revenue in Immunoinformatics Business (2018-2023) & (US$ Million)
Table 111. Nimbus Discovery Recent Development
Table 112. Strand Life Sciences Company Detail
Table 113. Strand Life Sciences Business Overview
Table 114. Strand Life Sciences Immunoinformatics Product
Table 115. Strand Life Sciences Revenue in Immunoinformatics Business (2018-2023) & (US$ Million)
Table 116. Strand Life Sciences Recent Development
Table 117. Schrodinger Company Detail
Table 118. Schrodinger Business Overview
Table 119. Schrodinger Immunoinformatics Product
Table 120. Schrodinger Revenue in Immunoinformatics Business (2018-2023) & (US$ Million)
Table 121. Schrodinger Recent Development
Table 122. Simulation Plus Company Detail
Table 123. Simulation Plus Business Overview
Table 124. Simulation Plus Immunoinformatics Product
Table 125. Simulation Plus Revenue in Immunoinformatics Business (2018-2023) & (US$ Million)
Table 126. Simulation Plus Recent Development
Table 127. Rosa & Co Company Detail
Table 128. Rosa & Co Business Overview
Table 129. Rosa & Co Immunoinformatics Product
Table 130. Rosa & Co Revenue in Immunoinformatics Business (2018-2023) & (US$ Million)
Table 131. Rosa & Co Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunoinformatics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Immunoinformatics Market Share by Type: 2022 VS 2033
Figure 3. Cancer Diagnosis & Therapy Features
Figure 4. Reverse Vaccinology Features
Figure 5. Immune System Modeling Features
Figure 6. Global Immunoinformatics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Immunoinformatics Market Share by Application: 2022 VS 2033
Figure 8. Allergy Prediction Databases Case Studies
Figure 9. Analysis Resource Database Case Studies
Figure 10. International Immunogenetics System Case Studies
Figure 11. The Ontology of Immune Epitopes Case Studies
Figure 12. Immune Epitope Database Case Studies
Figure 13. Immunoinformatics Report Years Considered
Figure 14. Global Immunoinformatics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Immunoinformatics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Immunoinformatics Market Share by Region: 2022 VS 2033
Figure 17. Global Immunoinformatics Market Share by Players in 2022
Figure 18. Global Top Immunoinformatics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunoinformatics as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Immunoinformatics Revenue in 2022
Figure 20. North America Immunoinformatics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Immunoinformatics Market Share by Country (2018-2033)
Figure 22. United States Immunoinformatics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Immunoinformatics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Immunoinformatics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Immunoinformatics Market Share by Country (2018-2033)
Figure 26. Germany Immunoinformatics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Immunoinformatics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Immunoinformatics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Immunoinformatics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Immunoinformatics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Immunoinformatics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Immunoinformatics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Immunoinformatics Market Share by Region (2018-2033)
Figure 34. China Immunoinformatics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Immunoinformatics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Immunoinformatics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Immunoinformatics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Immunoinformatics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Immunoinformatics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Immunoinformatics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Immunoinformatics Market Share by Country (2018-2033)
Figure 42. Mexico Immunoinformatics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Immunoinformatics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Immunoinformatics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Immunoinformatics Market Share by Country (2018-2033)
Figure 46. Turkey Immunoinformatics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Immunoinformatics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. EpiVax Revenue Growth Rate in Immunoinformatics Business (2018-2023)
Figure 49. Novozymes Biopharma Revenue Growth Rate in Immunoinformatics Business (2018-2023)
Figure 50. ioGenetics Revenue Growth Rate in Immunoinformatics Business (2018-2023)
Figure 51. International Society of Vaccines Revenue Growth Rate in Immunoinformatics Business (2018-2023)
Figure 52. IMGT Revenue Growth Rate in Immunoinformatics Business (2018-2023)
Figure 53. Dassault Systemes Revenue Growth Rate in Immunoinformatics Business (2018-2023)
Figure 54. Certara Revenue Growth Rate in Immunoinformatics Business (2018-2023)
Figure 55. Chemical Computing Group Revenue Growth Rate in Immunoinformatics Business (2018-2023)
Figure 56. Compugen Revenue Growth Rate in Immunoinformatics Business (2018-2023)
Figure 57. Genedata AG Revenue Growth Rate in Immunoinformatics Business (2018-2023)
Figure 58. Insilico Biotechnology AG Revenue Growth Rate in Immunoinformatics Business (2018-2023)
Figure 59. Leadscope Inc Revenue Growth Rate in Immunoinformatics Business (2018-2023)
Figure 60. Nimbus Discovery Revenue Growth Rate in Immunoinformatics Business (2018-2023)
Figure 61. Strand Life Sciences Revenue Growth Rate in Immunoinformatics Business (2018-2023)
Figure 62. Schrodinger Revenue Growth Rate in Immunoinformatics Business (2018-2023)
Figure 63. Simulation Plus Revenue Growth Rate in Immunoinformatics Business (2018-2023)
Figure 64. Rosa & Co Revenue Growth Rate in Immunoinformatics Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed